Global and promoter specific hypermethylation of tumor suppressor genes P16, SOCS1, and SHP1 in oral squamous cell carcinoma and oral submucous fibrosis

J Cancer Res Ther. 2023 Jan 1;19(Suppl 2):S551-S559. doi: 10.4103/jcrt.jcrt_689_22. Epub 2023 Apr 29.

Abstract

Aberrant methylation pattern leads to altered gene expression, that is, involved in the transformation of various cancers, including oral squamous cell carcinoma (OSCC). In the present study, an attempt has been made to examine the association of global and promoter-specific methylation of tumor suppressor genes in patients with OSCC and oral submucous fibrosis (OSMF). Promoter-specific methylation of tumor suppressor genes P16, SOCS1, and SHP1 had been studied earlier for their aberrant methylation patterns in other cancers; however, these studies were mainly conducted in-vitro or in animal models, and as such, only a few studies are available on human samples. In the present study evaluation of promoter-specific methylation of genes P16, SOCS1, and SHP1 in 76 patients' blood and tissue samples was done and compared with methylation of 35 healthy control samples using qPCR. Further, these samples were analyzed for global methylation patterns using ELISA. The results have shown a significant decreasing trend of promoter methylation (OSCC > OSMF > Controls); the methylation indices (MI) were significantly higher in OSCC than in the controls. The median MI of three genes for OSCC were P16MI (0.96), SHP1MI (0.79), and SOCS1 (0.80). Similarly, median MIs for OSMF were P16MI (0.18), SHP1 MI (0.19), and SOCS1 MI (0.5) against controls with MI (0) for each of the three genes. The global methylation %mC values were 1.9, 0.5, and 0.1, respectively. The values of MI and %mC were found to correlate with various risk factors such as tobacco, smoking, and alcohol consumption, which are positively involved in OSMF pathogenesis followed by oral cancer progression. Further, the methylation trend in tissue was reflected in blood samples, proving a window for methylation load to be used as a lesser invasive biomarker. The sensitivity and specificity of methylation load were also found reasonable. Therefore, the current study suggests that there may be a role of global and promoter-specific methylation load in the transition of OSMF to OSCC.

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • DNA Methylation
  • Genes, Tumor Suppressor
  • Head and Neck Neoplasms* / genetics
  • Humans
  • Mouth Neoplasms* / pathology
  • Oral Submucous Fibrosis* / genetics
  • Oral Submucous Fibrosis* / pathology
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6 / metabolism
  • Squamous Cell Carcinoma of Head and Neck / genetics
  • Suppressor of Cytokine Signaling 1 Protein / genetics
  • Suppressor of Cytokine Signaling 1 Protein / metabolism

Substances

  • SOCS1 protein, human
  • Suppressor of Cytokine Signaling 1 Protein
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6
  • CDKN2A protein, human